Experimental data published show that MIF suppression in breast cancer cell lines does not affect their proliferation in vitro but causes delayed tumor growth in mice, increasing the prevalence of an immune suppressive myeloid-derived population within the tumor (28,36). Here, MIF is linked to breast carcinoma.